Works matching IS 03407004 AND DT 2019 AND VI 68 AND IP 2
Results: 15
Can benign lymphoid tissue changes in <sup>18</sup>F-FDG PET/CT predict response to immunotherapy in metastatic melanoma?
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 297, doi. 10.1007/s00262-018-2279-9
- By:
- Publication type:
- Article
Tumor-infiltrating immune cell subpopulations and programmed death ligand 1 (PD-L1) expression associated with clinicopathological and prognostic parameters in ependymoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 305, doi. 10.1007/s00262-018-2278-x
- By:
- Publication type:
- Article
Upregulation of tumor PD-L1 by neoadjuvant chemoradiotherapy (neoCRT) confers improved survival in patients with lymph node metastasis of locally advanced rectal cancers.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 283, doi. 10.1007/s00262-018-2275-0
- By:
- Publication type:
- Article
A phase I clinical study of a cocktail vaccine of Wilms' tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 331, doi. 10.1007/s00262-018-2274-1
- By:
- Publication type:
- Article
Targeting the polarization of tumor-associated macrophages and modulating mir-155 expression might be a new approach to treat diffuse large B-cell lymphoma of the elderly.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 269, doi. 10.1007/s00262-018-2273-2
- By:
- Publication type:
- Article
Hyperresponsiveness to interferon gamma exposure as a response mechanism to anti-PD-1 therapy in microsatellite instability colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 257, doi. 10.1007/s00262-018-2270-5
- By:
- Publication type:
- Article
Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 233, doi. 10.1007/s00262-018-2267-0
- By:
- Publication type:
- Article
The nature of the human T cell response to the cancer antigen 5T4 is determined by the balance of regulatory and inflammatory T cells of the same antigen-specificity: implications for vaccine design.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 247, doi. 10.1007/s00262-018-2266-1
- By:
- Publication type:
- Article
Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 221, doi. 10.1007/s00262-018-2265-2
- By:
- Publication type:
- Article
Inhibitory functions of PD-L1 and PD-L2 in the regulation of anti-tumor immunity in murine tumor microenvironment.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 201, doi. 10.1007/s00262-018-2263-4
- By:
- Publication type:
- Article
The expression of MHC class II molecules on murine breast tumors delays T-cell exhaustion, expands the T-cell repertoire, and slows tumor growth.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 175, doi. 10.1007/s00262-018-2262-5
- By:
- Publication type:
- Article
INT-HA induces M2-like macrophage differentiation of human monocytes via TLR4-miR-935 pathway.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 189, doi. 10.1007/s00262-018-2261-6
- By:
- Publication type:
- Article
Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 213, doi. 10.1007/s00262-018-2256-3
- By:
- Publication type:
- Article
Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 163, doi. 10.1007/s00262-018-2253-6
- By:
- Publication type:
- Article
Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 2, p. 319, doi. 10.1007/s00262-018-2248-3
- By:
- Publication type:
- Article